Once-daily bupropion associated with improved patient adherence compared with twice-daily bupropion in treatment of depression

American Journal of Therapeutics

Volumn 14, Issue 2, 2007, Pages 221-225

  McLaughlin, Trent ^a,d   Hogue, Susan L ^b   Stang, Paul E ^c  

^a Wolters Kluwer   (United States)

^b GLAXOSMITHKLINE   (United States)

^c WEST CHESTER UNIVERSITY   (United States)

^d ELAN PHARMACEUTICALS   (United States)

Author keywords

Adherence; Antidepressant; Bupropion; Claims data; Medication possession ratio (MPR); Persistence; Pharmacy

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DEPRESSION; DISEASE CLASSIFICATION; DOSAGE SCHEDULE COMPARISON; DRUG DOSAGE FORM COMPARISON; DRUG DOSE REGIMEN; DRUG FORMULATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; TIME SERIES ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; DELAYED-ACTION PREPARATIONS; DEPRESSION; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SEX FACTORS;

EID: 34247145016     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000208273.80496.3f     Document Type: Conference Paper

References (12)

1. Clinical Practice Guideline, Number 5: Depression in Primary Care, 1: Detection and Diagnosis. Rockville, MD: US Department of Health and Human Services, Agency for Health Care Policy and Research; 1993. AHCPR Publication 93-0551.
2. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-3105.
3. Campbell LK, Robison LM, Skaer TL, et al. Depression: interventions and their effectiveness. Dis Manage Health Outcomes. 1997;2:223-237.
4. Eisenberg L. Treating depression and anxiety in primary care: closing the gap between knowledge and practice. N Engl J Med. 1992;326:1080-1084.
5. Simon GE, VonKorff M, Wagner EH, et al. Patterns of antidepressant use in community practice. Gen Hosp Psychiatry. 1993;5:399-408.
6. Simon GE, Lin EHB, Katon W, et al. Outcomes of "inadequate" antidepressant treatment. J Gen Intern Med. 1995;10:663-670.
7. Katzelnick DJ, Kobak KA, Jefferson KW, et al. Prescribing patterns of antidepressant medications for depression in an HMO. Formulary. 1996;31:374-388.
8. Drug Facts and Comparisons. St Louis, MO: Wolters Kluwer Co; 1997
9. Clinical Practice Guideline, Number 5: Depression in Primary Care, 2: Treatment of Major Depression. Rockville, MD: US Dept of Health and Human Services, Agency for Health Care Policy and Research; 1993. AHCPR Publication 93-0551.
10. Luce PJ. Asthma in the elderly. Br J Hosp Med. 1996;55:118-120.
11. Weiden PJ, Kozma C, Grogg A, et al. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv. 2004;55:886-891.
12. Mapel D, Pearson M. Obtaining evidence for use by health care payers on the success of chronic obstructive disease management. Respir Med. 2002;96(Suppl. C):S23-S30.